How Much Did PD-Rx Pharmaceuticals Raise?
Funding & Key Investors

PD-Rx Pharmaceuticals has solidified its market position through a significant capital infusion, bringing its total funding to $350K. This latest round, characterized by a $350K strategic investment, underscores the company's robust trajectory within the specialized healthcare distribution sector. By securing this financing, the firm is well-positioned to accelerate its operational footprint and enhance its service delivery model for medical practices nationwide.

What is PD-Rx Pharmaceuticals?

PD-Rx Pharmaceuticals
RetailDrug Stores & PharmaciesManufacturing

PD-Rx Pharmaceuticals, Inc. operates as a critical intermediary in the healthcare supply chain, providing comprehensive in-office physician dispensing solutions. The company distinguishes itself by integrating pharmaceutical product distribution with proprietary web-based software, enabling practitioners in primary care, urgent care, pain management, and dental fields to manage point-of-care dispensing with high efficiency. By facilitating direct-to-patient medication access, PD-Rx not only improves patient compliance and convenience but also serves as a vital revenue-generating partner for clinical practices. Their full-service distributorship model is designed to streamline the complexities of pharmaceutical logistics, allowing healthcare providers to focus on clinical outcomes while maintaining a sophisticated, compliant dispensing infrastructure.

How much funding has PD-Rx Pharmaceuticals raised?

PD-Rx Pharmaceuticals has raised a total of $350K across 1 funding round:

2020

Debt

$350K

Debt (2020): $350K with participation from PPP

Key Investors in PD-Rx Pharmaceuticals

PPP

Public-Private Partnership

What's next for PD-Rx Pharmaceuticals?

With the successful acquisition of this late-stage capital, PD-Rx Pharmaceuticals is poised to scale its technological infrastructure and expand its reach into underserved medical markets. The strategic focus will likely center on enhancing the interoperability of their point-of-care software, ensuring seamless integration with existing electronic health record systems. Furthermore, the company is expected to leverage this investment to optimize its supply chain logistics, potentially reducing overhead costs for its network of physician partners. As the healthcare industry continues to prioritize patient-centric care models, PD-Rx is strategically aligned to capitalize on the growing demand for integrated, in-office pharmaceutical services, thereby reinforcing its role as a leader in the medical distribution landscape.

See full PD-Rx Pharmaceuticals company page
See More Financial Insights
No matching results.
Refine your search.

Additional financial insights in the Retail industry

Home Improvement & Hardware RetailRetail
Home Improvement & Hardware RetailRetail
Other Rental Stores (Furniture, A/V, Construction & Industrial Equipment)RetailAmusement Parks, Arcades & AttractionsHospitality
FurnitureRetailManufacturingHousehold Goods

Frequently Asked Questions Regarding PD-Rx Pharmaceuticals Financial Insights

What are the most recent funding rounds that PD-Rx Pharmaceuticals has completed, and what were the funding rounds?
PD-Rx Pharmaceuticals has recently completed 1 funding rounds: Debt on Apr 6, 2020.
What is the total amount of funding PD-Rx Pharmaceuticals has raised to date?
PD-Rx Pharmaceuticals has raised a total of $350K in funding to date.
How many funding rounds has PD-Rx Pharmaceuticals completed?
PD-Rx Pharmaceuticals has completed 1 funding rounds.
How much funding did PD-Rx Pharmaceuticals raise in its most recent funding round?
PD-Rx Pharmaceuticals raised $350K in its most recent funding round.
Who are the lead investors in PD-Rx Pharmaceuticals's latest funding round?
The lead investor in PD-Rx Pharmaceuticals's latest funding round was PPP. To access investor data and explore similar companies, sign up for ZoomInfo.
Which was the largest funding round in PD-Rx Pharmaceuticals's history?
The largest funding round in PD-Rx Pharmaceuticals's history was $350K.
See more information about PD-Rx Pharmaceuticals